Research in this area is ongoing
BPC-157 modulates cytokine production, lowering pro-inflammatory signals (IL-6, TNF-alpha) while preserving or enhancing anti-inflammatory responses
Weeks 1 to 2: Most patients feel nothing different
Key variants in GLP1R (the GLP-1 receptor), GIPR (glucose-dependent insulinotropic peptide receptor), FTO (fat mass and obesity-associated gene), and MC4R (melanocortin 4 receptor) may affect medication sensitivity, baseline hunger signaling, and metabolic rate
Step 3: Targeted Peptide Layering Once hormones are optimized (typically 48 weeks), we layer in 12 targeted peptides based on your remaining symptoms
It should only be used in those with low thyroid function but you can pretty much guarantee that those with obesity have some level of thyroid dysfunction making it a great alternative